Actinium Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Actinium Pharmaceuticals has a total shareholder equity of $43.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $88.4M and $44.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$84.06m |
Equity | US$43.86m |
Total liabilities | US$44.50m |
Total assets | US$88.35m |
Financial Position Analysis
Short Term Liabilities: ATNM's short term assets ($85.4M) exceed its short term liabilities ($8.1M).
Long Term Liabilities: ATNM's short term assets ($85.4M) exceed its long term liabilities ($36.4M).
Debt to Equity History and Analysis
Debt Level: ATNM is debt free.
Reducing Debt: ATNM has no debt compared to 5 years ago when its debt to equity ratio was 3.3%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ATNM has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ATNM has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 3.9% each year.